IBM
IBM
$236.31
-0.41%
International Business Machines Corporation (IBM) is a global technology company that provides a broad portfolio of software, IT consulting services, and hardware, including hybrid cloud platforms and AI solutions like Red Hat and watsonx. As a veteran industry player operating in 175 countries and serving 95% of Fortune 500 companies, IBM holds a distinct position as a trusted enterprise technology partner, though it faces intense competition from more agile cloud and AI-native rivals. The current investor narrative centers on IBM's AI-driven transformation and its ability to monetize AI investments, but recent quarters have been marred by a software revenue miss and a profit warning, triggering a sharp sell-off and raising questions about the sustainability of its growth strategy. The stock's 25% plunge in July 2026 reflects concerns over customer spending shifts toward AI infrastructure, yet some analysts see a potential buying opportunity at lower valuations.…
IBM
IBM
$236.31
Related headlines
Investment Opinion: Should I buy IBM Today?
Rating: Hold. IBM's forward P/E of 17.72x and PEG of 0.35 suggest the stock is undervalued relative to its growth prospects, but the recent revenue decline and profit warning introduce significant uncertainty. The analyst consensus is Buy with an average target of $244.16, implying modest upside of 4.6%, which does not provide a compelling margin of safety given the risks.
Sign up to view all
IBM 12-Month Price Forecast
IBM's valuation is attractive on a forward basis, but the company's growth trajectory is uncertain. The AI narrative has not yet translated into revenue acceleration, and the profit warning suggests near-term headwinds. I would upgrade to bullish if IBM shows two consecutive quarters of revenue growth and software acceleration; I would downgrade to bearish if revenue declines persist and free cash flow deteriorates.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on IBM's 12-month outlook, with a consensus price target around $244.16 and implied upside of +3.3% versus the current price.
Average Target
$244.16
0 analysts
Implied Upside
+3.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$174 - $350
Analyst target range
The target price range spans from a low of $174.00 to a high of $350.00, representing a wide spread of $176, which signals significant uncertainty about IBM's future prospects. The high target of $350 assumes a strong recovery in software growth and successful AI monetization, potentially driving multiple expansion, while the low target of $174 implies continued revenue declines and margin compression, possibly due to competitive pressures and AI spending shifts. Recent institutional ratings show a mix of actions, with upgrades from JP Morgan (Overweight) and HSBC (Reduce), indicating divergent views. The wide range and mixed sentiment suggest that investors should expect high volatility and carefully weigh the risks and opportunities.
Drowning in data?
Find the real signal!
Bulls vs Bears: IBM Investment Factors
IBM presents a mixed picture: its forward valuation is attractive, free cash flow is robust, and margins remain healthy, but the company is grappling with revenue declines, a profit warning, and intense competitive pressure. The bear case currently has stronger evidence, as the recent software miss and customer spending shifts toward AI infrastructure directly threaten IBM's core growth segments. The most important tension is whether IBM's AI initiatives (watsonx, Red Hat) can reignite revenue growth, or whether the company will continue to lose ground to nimbler competitors. If AI monetization accelerates, the stock could re-rate toward the high target; if not, the low target becomes more plausible.
Bullish
- Attractive forward valuation: IBM trades at a forward P/E of 17.72x versus a trailing P/E of 26.07x, implying the market expects significant earnings growth. The PEG ratio of 0.35 suggests the stock is undervalued relative to its expected growth rate, making it appealing for value-oriented investors.
- Strong free cash flow generation: IBM generated $14.58 billion in trailing twelve-month free cash flow, providing ample capacity for dividends, debt reduction, and strategic investments. This robust cash flow supports the company's 2.27% dividend yield and its commitment to returning capital to shareholders.
- High gross margin and profitability: IBM's gross margin stands at 58.19%, with an operating margin of 18.50% and a net margin of 15.68%. These metrics demonstrate the company's ability to maintain profitability despite revenue headwinds, underpinning its earnings stability.
- Analyst consensus is Buy: With 23 analysts covering IBM, the consensus recommendation is 'Buy' with a mean rating of 2.12. The average target price of $244.16 implies about 4.6% upside from the current price of $233.43, while the high target of $350 suggests potential for substantial gains if AI monetization succeeds.
Bearish
- Revenue decline and profit warning: IBM's Q1 2026 revenue fell 6.2% year-over-year to $15.917 billion, and the company issued a profit warning in July 2026, citing a software revenue miss. This indicates weakening demand and raises concerns about the sustainability of its growth strategy.
- Significant underperformance vs. market: IBM's stock is down 7.47% over the past year, while the S&P 500 gained 21.46%. The 6-month decline of 21.91% and a maximum drawdown of -37.5% from its peak highlight the stock's poor relative performance and elevated downside risk.
- High debt levels: IBM's debt-to-equity ratio of 2.06 indicates substantial leverage, which increases financial risk, especially if interest rates remain elevated. The current ratio of 0.93 also suggests potential liquidity concerns, as current liabilities exceed current assets.
- Wide analyst target range signals uncertainty: The analyst target price ranges from $174 to $350, a spread of $176, reflecting deep uncertainty about IBM's future. The low target implies a potential 25.5% downside from the current price, while mixed recent ratings (JP Morgan upgrade, HSBC downgrade) underscore divergent views.
IBM Technical Analysis
IBM's price trend over the past year has been volatile and ultimately bearish, with the stock down 7.47% over the trailing 12 months, significantly underperforming the S&P 500's 21.46% gain. The current price of $233.43 sits at 70.2% of its 52-week range (between $199.19 low and $332.46 high), indicating a position closer to the lows than the highs, which suggests a market in a corrective phase rather than a sustained uptrend. The 6-month price change of -21.91% and a year-to-date decline of 19.92% further confirm a downtrend, with the stock having experienced a maximum drawdown of -37.5% from its peak.
Beta
0.70
0.70x market volatility
Max Drawdown
-37.5%
Largest decline past year
52-Week Range
$199-$332
Price range past year
Annual Return
-2.5%
Cumulative gain past year
| Period | IBM Return | S&P 500 |
|---|---|---|
| 1m | -17.8% | +2.4% |
| 3m | +7.8% | +4.7% |
| 6m | -13.4% | +11.7% |
| 1y | -2.5% | +21.3% |
| ytd | -18.9% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IBM Fundamental Analysis
IBM's revenue trajectory has been uneven, with the most recent quarter (Q2 2026) showing a significant miss, as revenue data is not fully available but the company issued a profit warning, and the prior quarter (Q1 2026) reported revenue of $15.917 billion, down from $16.977 billion in Q2 2025, reflecting a 6.2% year-over-year decline. Over the last four quarters, revenue has fluctuated: Q4 2025 saw $19.686 billion, Q3 2025 $16.331 billion, and Q2 2025 $16.977 billion, indicating a decelerating trend with recent quarters failing to show consistent growth. Segment data reveals that Software is the largest segment at $7.052 billion, followed by Consulting at $5.272 billion and Infrastructure Services at $3.326 billion, but the overall revenue decline suggests weakness across key areas, likely due to customers shifting spending toward AI infrastructure.
Quarterly Revenue
$0.0B
2026-06
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$14.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IBM Overvalued?
Given that IBM's net income is positive (e.g., $1.216 billion in Q1 2026), the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 26.07x, while the forward PE is 17.72x, indicating that the market expects earnings growth, as the forward multiple is significantly lower. This gap implies that analysts anticipate a substantial increase in earnings, which is supported by the estimated EPS of $12.56 for the next fiscal year, up from the current trailing EPS of approximately $8.95. The PEG ratio of 0.35 suggests that the stock is undervalued relative to its expected growth rate, but this is based on forward estimates that may be optimistic given recent headwinds.
PE
26.1x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 11x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: IBM's high debt-to-equity ratio of 2.06 and current ratio of 0.93 indicate elevated financial leverage and potential liquidity stress. The company's revenue has been declining, with Q1 2026 down 6.2% year-over-year, and the profit warning in July 2026 suggests further deterioration. Free cash flow of $14.58 billion is strong, but if revenue continues to fall, cash generation could weaken, impacting dividend sustainability (payout ratio 59%). Additionally, IBM's reliance on a few large segments (Software, Consulting, Infrastructure) makes it vulnerable to demand shifts in any one area.
FAQ
The key risks include: 1) Financial risk from high debt (debt-to-equity 2.06) and a current ratio of 0.93, which could strain liquidity if cash flow weakens. 2) Competitive risk from AI-native companies like Pegasystems, which are winning customers with more agile solutions. 3) Macro risk from a potential economic slowdown that could reduce IT spending, as evidenced by the recent software revenue miss. 4) Company-specific risk of continued revenue decline, which could lead to dividend cuts if free cash flow deteriorates. The most severe risk is a prolonged downturn in software sales, which could push the stock toward the $174 low target.
The 12-month forecast is mixed: the base case (50% probability) sees the stock trading around $244, the bull case (25%) targets $280-$350, and the bear case (25%) could see it fall to $174-$210. The base case assumes revenue stabilizes and the company meets estimates, while the bull case requires successful AI monetization. The bear case would materialize if revenue declines accelerate. Given the recent profit warning, the base case is most likely, but investors should monitor quarterly earnings for signs of improvement or deterioration.
IBM's trailing P/E of 26.07x is above the market average, but the forward P/E of 17.72x suggests the market expects earnings growth. The PEG ratio of 0.35 indicates the stock is undervalued relative to its expected growth rate, which is a positive signal. Compared to its own history, IBM's valuation is in line with its 5-year average, but the recent earnings decline has made the forward multiple more attractive. Overall, IBM appears fairly valued to slightly undervalued, but the market is pricing in a recovery that has yet to materialize.
IBM is a good buy for value investors with a long-term horizon, given its forward P/E of 17.72x and PEG of 0.35, which suggest undervaluation. The stock offers a 2.27% dividend yield and strong free cash flow of $14.58 billion, providing downside support. However, the recent profit warning and revenue decline introduce significant risk, so investors should wait for evidence of stabilization before initiating a position. The analyst consensus is Buy with an average target of $244.16, implying modest upside, but the wide target range ($174-$350) highlights uncertainty.
IBM is more suitable for long-term investment due to its low beta (0.705), stable dividend, and potential for AI-driven growth over time. Short-term trading is risky given the high volatility (recent 25% drop) and uncertain near-term catalysts. The company's growth stage is mature, but its transformation to hybrid cloud and AI could drive multi-year appreciation. A minimum holding period of 3-5 years is recommended to allow the AI strategy to bear fruit and for the stock to recover from its current downturn.
